GenAI in Healthcare, Life sciences and Pharma: Navigating the road to full-scale implementation and impact
Listen to this blog
Introduction
Generative AI (GenAI) holds transformative potential in the Life sciences, Pharmaceutical, and Healthcare industries. From accelerating drug discovery and improving diagnostics to enhancing personalized treatment plans, GenAI is poised to revolutionize these sectors. In fact, McKinsey estimates that GenAI could unlock between $60 billion to $110 billion annually for the Pharmaceutical industry alone by enhancing drug discovery processes and speeding up clinical trials.